Literature DB >> 6230705

Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

A Laffón, J Alcocer-Varela, D Alarcón-Segovia.   

Abstract

Kinetic studies of autologous mixed lymphocyte reaction (AMLR) over 7 days were made in 86 patients with various connective tissue diseases. None was receiving any treatment and each disease group was controlled with age-sex matched healthy controls. There were exceptions, but, as a rule, SLE patients (n = 22) had decreased responses on days 6-7. This was more apparent in patients with active disease than in those with inactive disease. Patients with scleroderma (n = 21) had early (day 4) proliferative responses. Half of the patients with RA (n = 14) had early (day 3) proliferation, but as a group they had normal increase in 3HtdR uptake on day 7. Patients with primary Sjögren's syndrome showed flat curves throughout and no significant proliferation on days 6-7 of culture. The pattern found in patients with mixed connective tissue disease (n = 11) was also peculiar in that they had peak proliferative responses on day 3 and normal 3HtdR uptake on days 6 and 7 of the AMLR. The number of patients with dermatomyositis or polymyositis was small (n = 6), but they showed a significant mean decrease in uptake on days 6-7. Studies using subpopulations of stimulatory cells further indicate that these patterns reflect immunoregulatory disturbances peculiar to each disease.

Entities:  

Mesh:

Year:  1983        PMID: 6230705     DOI: 10.1007/bf00541191

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  42 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response.

Authors:  K Okudaira; R P Searles; J S Goodwin; R C Williams
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  Human post-thymic precursor cells in health and disease. V. Stimulatory effect of serum thymic factor on the cell cycle of autologous-rosette forming and T gamma-cells.

Authors:  R Palacios; L Llorente; A Ruiz-Arguelles; D Alarcon-Segovia
Journal:  Immunol Lett       Date:  1982-01       Impact factor: 3.685

5.  Self recognition by autologous mixed lymphocyte reaction-primed cells.

Authors:  K Tomonari; A Wakisaka; M Aizawa
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor.

Authors:  R Palacios; D Alarcón-Segovia; L Llorente; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  J Clin Lab Immunol       Date:  1981-03

7.  Articular manifestations of mixed connective tissue disease.

Authors:  F Ramos-Niembro; D Alarcón-Segovia; J Hernández-Ortíz
Journal:  Arthritis Rheum       Date:  1979-01

8.  The autologous mixed lymphocyte reaction in systemic lupus erythematosus.

Authors:  P J Riccardi; P B Hausman; H V Raff; J D Stobo
Journal:  Arthritis Rheum       Date:  1982-07

9.  Contrasuppression. A novel immunoregulatory activity.

Authors:  R K Gershon; D D Eardley; S Durum; D R Green; F W Shen; K Yamauchi; H Cantor; D B Murphy
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  3 in total

1.  A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome.

Authors:  J Alcocer-Varela; A Laffon; C Abud-Mendoza; D Alarcon-Segovia
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

2.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

3.  Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.